Rolf A Brekken Selected Research

Rolf A Brekken Research Topics

Disease

119	Neoplasms (Cancer) 01/2022 - 10/2002
35	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2004
25	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2003
21	Adenocarcinoma 01/2022 - 03/2005
13	Breast Neoplasms (Breast Cancer) 11/2020 - 09/2006
11	Hypoxia (Hypoxemia) 06/2021 - 09/2003
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2003
8	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2010
5	Carcinogenesis 11/2020 - 08/2010
4	Melanoma (Melanoma, Malignant) 01/2016 - 12/2011
3	Obesity 01/2021 - 12/2017
3	Fibrosis (Cirrhosis) 11/2020 - 08/2009
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 04/2015
3	Carcinoma (Carcinomatosis) 10/2018 - 09/2012
3	Insulin Resistance 10/2018 - 04/2012
3	Inflammation (Inflammations) 08/2013 - 07/2012
2	Adenocarcinoma of Lung 01/2022 - 10/2013
2	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2021
2	Pancreatitis 11/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 12/2016
2	Type 2 Diabetes Mellitus (MODY) 10/2018 - 09/2010
2	Fatty Liver 10/2018 - 12/2017
2	Weight Loss (Weight Reduction) 10/2018 - 10/2007
2	Thrombosis (Thrombus) 01/2016 - 09/2015
2	Endometrial Neoplasms (Endometrial Cancer) 11/2015 - 07/2010
2	Choroidal Neovascularization 11/2015 - 02/2006
2	Necrosis 01/2011 - 09/2003

Drug/Important Bio-Agent (IBA)

46	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2004
25	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2005
15	CollagenIBA 01/2021 - 04/2004
12	PhosphatidylserinesIBA 01/2021 - 05/2006
11	Gemcitabine FDA Link 01/2022 - 05/2006
9	Monoclonal AntibodiesIBA 01/2016 - 09/2003
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022 - 10/2015
8	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2013 - 08/2006
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2016
7	Pharmaceutical PreparationsIBA 12/2021 - 01/2011
7	CytokinesIBA 11/2020 - 06/2008
7	LigandsIBA 01/2017 - 10/2002
7	IntegrinsIBA 10/2016 - 03/2005
6	Biological ProductsIBA 01/2022 - 06/2013
6	Phosphotransferases (Kinase)IBA 01/2019 - 08/2013
6	Cysteine (L-Cysteine)FDA Link 02/2013 - 02/2009
5	Discoidin Domain Receptor 1IBA 01/2020 - 01/2017
5	Bevacizumab (Avastin)FDA Link 03/2016 - 05/2009
5	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2014 - 08/2006
4	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2005
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 07/2015
4	c-Mer Tyrosine KinaseIBA 01/2021 - 11/2018
4	Interleukin-6 (Interleukin 6)IBA 11/2019 - 11/2009
4	Estrogens (Estrogen)FDA Link 01/2019 - 09/2006
4	Indicators and Reagents (Reagents)IBA 08/2017 - 10/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016 - 05/2010
4	EnzymesIBA 11/2013 - 08/2006
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2012 - 02/2003
3	AntibodiesIBA 01/2018 - 08/2013
3	Fibrillar CollagensIBA 11/2017 - 08/2009
3	Phospholipids (Phosphatides)FDA LinkGeneric 08/2017 - 01/2016
3	PeptoidsIBA 05/2016 - 07/2010
3	Therapeutic UsesIBA 01/2016 - 05/2006
3	GTP-Binding Proteins (G-Protein)IBA 12/2015 - 07/2010
3	Small Interfering RNA (siRNA)IBA 01/2011 - 07/2005
2	AngiopoietinsIBA 01/2022 - 02/2014
2	Transcription Factors (Transcription Factor)IBA 06/2021 - 12/2017
2	CeruletideIBA 11/2020 - 01/2019
2	Axl Receptor Tyrosine KinaseIBA 01/2020 - 09/2015
2	Cadherins (E-Cadherin)IBA 11/2019 - 12/2011
2	tyrosine receptor (receptor, tyrosine)IBA 11/2018 - 08/2013
2	bemcentinibIBA 01/2018 - 10/2015
2	Adenosine Triphosphate (ATP)IBA 11/2017 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 11/2009
2	Fibronectins (Fibronectin)IBA 10/2016 - 10/2016
2	CarbohydratesIBA 05/2016 - 12/2015
2	LipidsIBA 05/2016 - 12/2015
2	Peptides (Polypeptides)IBA 05/2016 - 12/2015
2	Antineoplastic Agents (Antineoplastics)IBA 12/2015 - 09/2012
2	Warfarin (Coumadin)FDA LinkGeneric 10/2015 - 09/2015
2	CXC ChemokinesIBA 04/2015 - 05/2014
2	nintedanibIBA 03/2015 - 06/2013
2	Neutralizing AntibodiesIBA 05/2014 - 11/2007
2	Cell Surface ReceptorsIBA 02/2014 - 08/2010
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2013 - 11/2012
2	apricoxibIBA 09/2012 - 09/2012
2	matrigelIBA 12/2010 - 10/2007
2	Neuropilin-1IBA 08/2010 - 10/2008
2	pleiotrophin (HARP)IBA 05/2010 - 06/2008
2	Immunoglobulin G (IgG)IBA 07/2009 - 01/2007
2	Extracellular Matrix ProteinsIBA 02/2009 - 03/2005
2	Angiogenesis InhibitorsIBA 10/2007 - 10/2007
2	Progestins (Progestagens)IBA 10/2007 - 09/2006
1	dubermatinibIBA 01/2022
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Interferon Type IIBA 01/2022

Therapy/Procedure

63	Therapeutics 01/2022 - 10/2003
16	Drug Therapy (Chemotherapy) 01/2022 - 05/2006
4	Immunotherapy 01/2022 - 01/2018
4	Aftercare (After-Treatment) 01/2021 - 10/2004
3	Transplantation 11/2020 - 09/2009
2	Blood Transfusion (Blood Transfusions) 08/2010 - 05/2009